Oral Answers to Questions

Mark Pawsey Excerpts

Tuesday 19th February 2019 Commons Chamber

[Matt Hancock]

In the event of a problem at the Dover-Calais strait, we will bring in radioisotopes by air, and we have already contracted an aircraft to ensure that that happens. That part of the planning is well advanced.

[Mark Pawsey (Rugby) (Con)]

On Thursday, with Rugby’s mayor, I had the great pleasure to open the new Brownsover surgery, which came about because of the hard work of the patient action group. Will the Secretary of State welcome the work of patient groups in delivering NHS services?

[Matt Hancock]

I am absolutely delighted to welcome the work of the group, which has raised so much money, and of my hon. Friend, who stands up and makes the case for Rugby. More broadly, we should welcome all those who want to make a contribution to our hospitals and hospices. We take a broad-minded and open approach to welcoming people who volunteer hours or raise money to improve our great NHS.

Leaving the EU: Tobacco Products and Public Health

Mark Pawsey Excerpts

Monday 7th January 2019 Commons Chamber

[Mark Pawsey (Rugby) (Con)]

I want to follow the remarks of the hon. Member for Central Ayrshire (Dr Whitford) about the impact of these regulations on vaping products. The vaping industry welcomes the Government’s sensible planning, but has a particular concern about products that are already registered with the EU. The industry producing such products is looking for some clarification from the Minister and some assurance about whether products that are already registered will need to be re-registered under the new UK-based system.

The Minister has spoken about the opportunity to reappraise our legislation. Of course, e-cigarettes are controlled by the tobacco products regulations, despite there not being any tobacco at all in such products. There are three issues that are of concern to users in particular. The first is the cap on nicotine strength in vaping liquids. In many cases, it is too low to encourage heavy smokers to switch to e-cigarettes, which we know are far better for their health and which we want to encourage. There are restrictions on both the size of bottle in which vaping liquids can be sold and the tank size of vaping devices, both of which appear to be completely arbitrary, with no basis to them.

Both users of e-cigarettes and the manufacturing sector are hoping that this may be an opportunity for the Minister to rectify the regulations, which, frankly, are nonsensical. I look forward to the Minister’s response on those points.

Medicines and Medical Devices Safety Review

Mark Pawsey Excerpts

Wednesday 21st February 2018 Commons Chamber

[Mr Hunt]

This is something for Baroness Cumberlege to consider, but the broader point is right. We have for too long in each of these three cases, and in others as well, had processes that have not had the confidence of patients. That is why we are proposing today not just specific measures on each of the three issues, but a broader look at the regulatory structure to make sure that patients’ voices are louder and we avoid precisely what the hon. Lady said.

[Mark Pawsey (Rugby) (Con)]

I welcome today’s announcement, which I am sure will also be welcomed by my constituent who had surgical mesh implanted in 2008 during a hysterectomy, and, significantly, without her knowledge or consent, which has led her to suffer severe distress and significant pain. When she raised that with her doctors, she was told it was all in her mind and she was imagining it, and she believes that she is still not being taken seriously 10 years later. Does the Secretary of State share my hope that the very existence of the review will encourage a more sympathetic response to people such as my constituent from the medical profession?

[Mr Hunt]

I very much hope so, and the crucial point that has come out from the contributions of Members in all parts of the House is that the processes we have had in place to date have not had the confidence of the families affected. That applies to a whole range of issues, and I believe medicine is changing fundamentally: people who are passionate about medical innovation and life sciences know that we need to have a very close partnership with patients in order to make proper advances. But we have not always got this right, and that is what I hope Baroness Cumberlege’s review will help us to do.

Oral Answers to Questions

Mark Pawsey Excerpts

Tuesday 19th December 2017 Commons Chamber

[Mr Hunt]

That area will obviously be very important in the negotiations, but we have made our preference clear: a deep and special partnership with the EU in which the benefits of co-operation that we currently have can continue.

[Mark Pawsey (Rugby) (Con)]

T6. Public Health England has stated that e-cigarettes are at least 95% safer than tobacco products and are now the most popular way to stop smoking. What is being done to encourage smokers to quit using this method, and what steps are being taken to ensure that e-cigarette users are not forced to share their space with people who continue to smoke?

[Steve Brine]

The truth is that we do not yet know enough about e-cigarettes. I welcome the Science and Technology Committee’s investigation into them. We have asked Public Health England to include messages about the relative safety of e-cigarettes in its Quit Smoking campaign next month, but it is for local organisations and businesses to implement their own policies on e-cigarette use in the workplace.

Hormone Pregnancy Tests

Mark Pawsey Excerpts

Thursday 14th December 2017 Commons Chamber

[Mark Pawsey (Rugby) (Con)]

I congratulate my right hon. Friend the Member for Hemel Hempstead (Sir Mike Penning) on securing this debate. I add my weight and support to his call for a statutory inquiry into the scandal of the supply of Primodos as a pregnancy test. He drew attention to the years that the product was in use. Like him, I am a product of 1957, and it could just as easily have been my mother taking this drug. Hon. Members across the Chamber have mentioned their constituents, and it is contact with one of my constituents that brings me to contribute to today’s debate.

The resident who came to see me and who has contacted me on many occasions is Irene Creed, who lives in Long Lawford in my constituency. I owe Mrs Creed something of an apology because I am afraid that I gave a rather standard reply at our first point of contact. I did not really know or understand enough about the issues that were affecting Mrs Creed. However, she continued to write to me and to draw my attention to the issue. We eventually met in June 2014 and then again at my surgery in August 2015, when she brought along her daughter, Tamara. Tamara was born in February 1973, which means that she is now 44. Like the constituent of my hon. Friend the Member for North Devon (Peter Heaton-Jones), Mrs Creed was able to tell me the very date on which she was first given Primodos. It was 19 June 1972, when she understood that she was approximately seven to eight weeks pregnant. She gave birth to a daughter with brain damage, which has led to other debilitating conditions such as learning difficulties and epilepsy.

When we met, Mrs Creed asked me to meet Marie Lyon, who runs the Association for Children Damaged by Hormone Pregnancy Tests. I think we should pay tribute to the association for the work that it has done in drawing attention to the issue and for ensuring that the Members who are present today were informed and knew exactly what had happened.

The other key point made by Mrs Creed was that she was given no advice whatsoever about any side-effects of the drug. She drew my attention to the many meetings of the all-party parliamentary group on oral hormone pregnancy tests. I know that the hon. Member for Bolton South East (Yasmin Qureshi) has done a tremendous amount of work in bringing together the members of the APPG and adding to the lobbying on this issue.

The most recent contact that I have had about the issue was with Tamara herself, who began her letter of 23 November by telling me that she was a victim of Primodos. She referred to the inadequate nature of the report produced by the expert working group and set out the case made by my right hon. Friend the Member for Hemel Hempstead for a further look at the issue, which many other Members have also requested. I agree with my right hon. Friend that we badly need to get to the truth, and, like everyone else who is present today, I look forward to whatever positive remarks the Minister may be able to make.

Tobacco Control Plan

Mark Pawsey Excerpts

Thursday 19th October 2017 Commons Chamber

[Sir Kevin Barron]

Clearly that is the case. I agree with this publication and its intention, but there will be issues to address on different forms of funding. I will discuss that a little later in my speech. We can see from the two figures from central London and Blackpool that there is a challenge out there; this difference alone can have a dramatic impact on health inequalities, as maternal smoking causes up to 5,000 miscarriages, 300 perinatal deaths and 2,200 premature births in the UK each year.

In my area of Rotherham alone, the smoking rate among people in managerial and professional occupations is about 10.2%, but that leaps to 29.4% among those who have never worked or are long-term unemployed. Such facts clearly show that we are still struggling to get through to certain groups within society, and the Government must do more to identify ways of getting through to these difficult-to-reach groups.

[Mark Pawsey (Rugby) (Con)]

The right hon. Gentleman is setting out the harm caused by tobacco. As a recent convert to the benefit of e-cigarettes in assisting people to stop smoking, I wonder whether he will be talking about the valuable role they play. Does he agree that it is a bit of a shame that the tobacco control plan does not go further in recognising the role that e-cigarettes can play?

[Sir Kevin Barron]

I will comment on that, but I think the hon. Gentleman ought to be happy that this is the first time in any tobacco control plan that e-cigarettes have been mentioned and there is some intent to do things with them.

I welcome the acknowledgment of the seriousness of the issue for people with long-standing mental health problems, as the smoking rate is a staggering 40% among those with a serious mental illness. That is another area that needs to be targeted and worked on. The control plan rightly states that joined-up working and integrated commissioning between local government and the NHS are very important. This is not just the case in hospitals when people are admitted; we must focus on prevention and early diagnosis. For example, dentists are the only healthcare professionals who frequently see healthy patients and so are in an excellent position to identify possible oral health problems early on.

--- Later in debate ---

[Sir Kevin Barron]

I actually had this conversation in Leicester, although I was not going to mention it in my speech. There is an issue—I think it was in a column in one of the national newspapers many months ago and I have tried to avoid it. If somebody avoids spending £20 or £25 a week on cigarettes, should they get free NHS prescriptions, if they are eligible, to help them to quit? There is a debate there, but I shall say no more than that at this stage.

I asked the team in Leicester what they thought about e-cigarettes on prescription for people who are eligible for free prescriptions, and they said that there might be a case for doing it for a month to break the person away from the cigarette-smoking habit and get them on to e-cigarettes. For the purposes of this debate, I shall leave that where it sits, but there might be a case for it. We clearly need more evidence on the use of e-cigarettes for smoking cessation so that we can make a better estimate.

[Mark Pawsey]

I accept that the right hon. Gentleman wishes to park the issue of whether e-cigarettes should be available on prescription, but does he think that e-cigarette manufacturers should have a little more freedom—the tobacco products directive places restrictions on the advertising of e-cigarettes—to tell people about the nature of their products and how they can help people to switch from tobacco?

[Sir Kevin Barron]

I shall address that briefly, because I know that other Members wish to get involved in the debate. The simple answer is that that is one of several issues that need to be addressed.

The best thing smokers can do for their health is of course to quit smoking altogether, but it is clear that e-cigarettes are significantly less harmful to health than smoking tobacco. Public Health England found that e-cigarettes are around 95% less harmful than smoking cigarettes. My instinct is that the remaining 5% is down to the fact that they have not yet been tested for long enough for it to be said that there is little or no danger at all. There is no evidence that e-cigarettes act as a smoking gateway for children or non-smokers, but research is still needed on their long-term use, and it should be carried out. Quitting smoking is always best, but there is clearly a hard core of smokers who have so far struggled to quit; they must be the people we focus on. It is worrying that an ASH survey found over a three-year period that the number of people who thought that e-cigs were “as or more dangerous” than cigarettes rose from 7% to 26%. That is why we need Government-funded research. I find it incredible that statistic is moving in that direction, rather than the opposite, although I must say that the debate on e-cigarettes, both in the Chamber and elsewhere, has not always been particularly clear.

Other innovations are continuing the “nicotine revolution”. Manufacturers are developing additional smoke-free products to persuade heavy smokers who would not otherwise quit smoking to switch to smoke-free alternatives, among which are the heated-tobacco products that have come on to the scene in the past year or so. Referred to in the “novel tobacco products” category of the tobacco control plan, such products could be the next step to reaching those hard-core smokers who, although they did not get on with e-cigarettes, are looking for another way out of smoking. I was pleased to see in the plan that Public Health England will continue to lead the investigation into the use of novel products as stop-smoking tools, with the evidence updated annually, and that PHE acknowledges that novel products are currently the most popular aid to stopping smoking in England.

Many people are wary of so-called novel products and the fact that many are produced or funded by tobacco companies. We must recognise that tobacco companies have in the past been extremely dishonest about the harms of smoking and the products they have sold, so we urgently need more research on these devices, and I hope the Government’s annual review will help to provide more information. I have been anti-tobacco for more than two decades in this House, but we should not ignore the potential benefits for people who have not been able to stop with more traditional smoking-cessation products just because some of these products have tobacco connections. It is vital that we all focus our minds on the reality of getting people off this habit that is still killing people and shortening the lives of more than 100,000 of our fellow citizens every year.

Many of the products I am talking about are covered by the EU tobacco product directive, which has resulted in many good things, including the establishment of reporting and notification requirements for tobacco products. Nevertheless, stakeholders have raised issues with some of the other requirements, and we may be able to use Brexit as a chance to look at the directive. I understand that we have been thrown into the TPD at the last minute. We have had the debate and I do not want to bore anyone with it further. We need to move on, because that is what happens in politics sometimes. We need to talk about what should be happening now and in future for the sake of our fellow citizens. Brexit is coming, so we should not be tied into a timetable for any changes to the TPD—although I do not even know the potential timetable for any further debate on Brexit. Nevertheless, if there is any discussion about changes to the TPD, we need to ensure that all stakeholders are involved in working groups to design a directive that works for the good of the United Kingdom, taking into account the issues I have mentioned.

For all its positives, there is a glaring problem with the tobacco control plan, and we all know what it is: money. Although not short on lofty ambitions, local authorities face huge strain and will not be able to deliver the kind of joined-up smoking-cessation services that the tobacco control plan deserves. Luckily, there are people who can help. Tobacco companies have made a fortune selling cigarettes. We might well argue that they got us into the mess we are now in, so it is only right they get should us out of it. They have the resources and customer base to help smoking cessation tools to get straight to the people who need them most. If the industry is willing to commit to a future based on e-cigarettes and other reduced-harm products, we should take them up on the offer and allow the Government and local authorities to partner with them to ensure we have the financial and technical assistance needed to help smokers to quit. I would not have said that five years ago, but five years ago we did not have these products that can clearly help a lot of our fellow citizens to get off cigarettes.

Contaminated Blood

Mark Pawsey Excerpts

Tuesday 11th July 2017 Commons Chamber

[Kevin Hollinrake (Thirsk and Malton) (Con)]

I, too, start by paying tribute to the hon. Member for Kingston upon Hull North (Diana Johnson) for her leadership and persistence on this issue, on which she and my hon. Friend the Member for Stratford-on-Avon (Nadhim Zahawi) have done tireless work. I welcome the Minister’s statement that a public inquiry will happen on this most important of issues. The Prime Minister has clearly listened to views across the House on the matter.

At one of my first surgery appointments, Richard and his wife came to see me to tell me his story. Richard was a haemophiliac who was sent to a school for the physically disabled in Hampshire when he was 11. For six years, he was given hundreds of thousands of units of factor VIII. Prior to that he had been given cryoprecipitate, which was perfectly workable in moderating his condition. The factor VIII prophylactic treatment was meant to prevent the dangers caused by haemophilia. It changed Richard’s life. Sadly, 64 of the 75 people from Richard’s school are no longer with us. Many of those young people died in their early teens.

This case is a double tragedy. Richard and his wife told me the very good news that, in later life, they decided to have children, but due to the risk of his hepatitis affecting the unborn baby, they had to have a termination, so they are childless as well as having been affected by terrible diseases throughout their lives.

I neglected to congratulate the hon. Member for Oxford East (Anneliese Dodds) on her very fine maiden speech. She certainly made a far better job of it than I did of mine when I stood here two years ago. Her tremendous words were highly relevant to the topic under discussion. I am sure she will make many further fine contributions in the years ahead.

[Mark Pawsey (Rugby) (Con)]

Does my hon. Friend agree that the inquiry needs to consider the challenges faced by people affected by contaminated blood who want children? A constituent of mine had one round of IVF treatment covered by the NHS, but he was not entitled to a second round, so he had to pay for it himself. We should consider such issues and their effect on people in the round.

Oral Answers to Questions

Mark Pawsey Excerpts

Tuesday 4th July 2017 Commons Chamber

[Steve Brine]

I am very happy to do that.

[Mark Pawsey (Rugby) (Con)]

Following the closure of their GP surgery, my constituents in Brownsover have had to make do without one over the past few years. Approvals are in place for a new surgery and it is due to open next summer. Will the Minister confirm that the timeline set out by NHS England will be met?

[Steve Brine]

I will ask NHS England, but if that is what it has told my hon. Friend, that is what will happen.

Oral Answers to Questions

Mark Pawsey Excerpts

Tuesday 7th February 2017 Commons Chamber

[Mr Hunt]

Dudley CCG has seen its funding go up, and we are asking all CCGs to increase the proportion of their spend on mental health. I am happy to look into the situation the hon. Gentleman talks about, but I will be very disappointed if increasing resources are not going into mental health provision in Dudley.

[Mark Pawsey (Rugby) (Con)]

Will the Secretary of State say a little more about how children’s mental health services can work more closely with schools and the education system more broadly?

[Mr Hunt]

I am happy to do that. Some interesting innovation is going on in many parts of the country. In Hove, a school I visited has a CAMHS––child and adolescent mental health services—worker based full-time in the school. That had a transformational effect, as it meant teachers always had someone they knew they could talk to and their understanding of mental health improved. That is the kind of innovation we want to encourage.

Oral Answers to Questions

Mark Pawsey Excerpts

Tuesday 20th December 2016 Commons Chamber

[Mr Jeremy Hunt]

We are taking action and I agree with the right hon. Gentleman that what has happened in that case is completely unacceptable. We are currently commissioning a record number of in-patient mental health beds, and it is a very big priority for us to eliminate the problem entirely by the end of the Parliament.

[Mark Pawsey (Rugby) (Con)]

My constituent Marie Bingham administers a drug at home using pre-filled syringes, but she is unable to dispose of the used needles, partly because they are in 2.5 litre sharps tubs rather than 1 litre sharps tubs. It is a ludicrous situation. Is the Minister aware of the problem, and are there any steps he can take to deal with it?

[David Mowat]

As my hon. Friend says, pharmacies are commissioned, on such occasions, to dispose of these needles. I was not aware of the particular issue about the 2.5 litre tubs that seems to exist in Rugby. I will investigate that and revert to him.